Original Research

Open Clinical Trials for Native Americans With Diabetes Mellitus


 

Growing Resilience in Wind River Indian Reservation (GR)

The Growing Resilience research leverages reservation-based assets of land, family, culture, and front-line tribal health organizations to develop and evaluate home food gardens as a family-based health promotion intervention to reduce disparities suffered by Native Americans in nearly every measure of health. Home gardening interventions show great promise for enabling families to improve their health, and this study aims to fulfill that promise with university and Wind River Indian Reservation partners. The investigators will develop an empowering, scalable, and sustainable family-based health promotion intervention with, by, and for Native American families and conduct the first randomized controlled trial to assess the health impacts of home gardens.

ID: NCT02672748
Sponsor: University of Wyoming
Location: University of Wyoming, Laramie


A Comparative Effectiveness Study of Major Glycemia-lowering Medications for Treatment of Type 2 Diabetes (GRADE)

The GRADE Study is a pragmatic, unmasked clinical trial that will compare commonly used diabetes medications, when combined with metformin, on glycemia-lowering effectiveness and patient-centered outcomes.

ID: NCT01794143
Sponsor: GRADE Study Group
Location: Southwestern American Indian Center, Phoenix, AZ


Home-Based Kidney Care in Native Americans of New Mexico (HBKC)

New Mexico American Indians are experiencing an epidemic of chronic kidney disease due primarily to the high rates of obesity and diabetes. The present study entitled Home-Based Kidney Care is designed to delay / reduce rates of end stage renal disease by early interventions in chronic kidney disease (CKD). Investigators propose to assess the safety and efficacy of conducting a full-scale study to determine if home based care delivered by a collaborative team composed of community health workers, the Albuquerque Area Indian Health Board and University of New Mexico faculty will decrease the risk for the development and the progression of CKD.

ID: NCT03179085
Sponsor: University of New Mexico
Contact: Vallabh Shah, PhD, vshah@salud.unm.edu; Kevin English, PhD, kenglish@aaihb.org
Location: University of New Mexico, Albuquerque

Pages

Recommended Reading

Open Clinical Trials for Diabetes Mellitus Harm Reduction (FULL)
Federal Practitioner
CONCLUDE data inconclusive on hypoglycemia risk for degludec vs. glargine
Federal Practitioner
Smoking, inactivity most powerful post-MI lifestyle risk factors
Federal Practitioner
Clinical Pharmacists Improve Patient Outcomes and Expand Access to Care
Federal Practitioner
Certain diabetes drugs may thwart dementia
Federal Practitioner
Dapagliflozin approved for reducing HF hospitalization in diabetes
Federal Practitioner
Severe hypoglycemia, poor glycemic control fuels fracture risk in older diabetic patients
Federal Practitioner
SUSTAIN 10: Weight loss, glycemic control better with semaglutide than liraglutide
Federal Practitioner
A Health Care Provider Intervention to Address Obesity in Patients with Diabetes (FULL)
Federal Practitioner
Evaluating a Program Process Change to Improve Completion of Foot Exams and Amputation Risk Assessments for Veterans with Diabetes (FULL)
Federal Practitioner

Related Articles

  • Pharmacology

    Clinical Pharmacists Improve Patient Outcomes and Expand Access to Care

    The United States Public Health Service National Clinical Pharmacy Specialist Committee issues a report on the impact of pharmacy-managed clinics...